Tenax Therapeut

TENX NASDAQ
1.180
+0.010
+0.85%
Closed 16:00 08/22 EDT
Open
1.170
Prev Close
1.170
High
1.210
Low
1.170
Volume
18.50K
Avg Vol (3M)
82.84K
52 Week High
6.39
52 Week Low
1.030
% Turnover
0.27%
Market Cap
7.95M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Tenax Therapeut TENX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.
MORE >

Recently

Name
Price
%Change